FDA Approves ACETAZOLAMIDE — ANI Pharmaceuticals, Inc.

# FDA Approves ANI Pharmaceuticals' Generic Acetazolamide ANI Pharmaceuticals, Inc. received FDA approval for its generic acetazolamide oral formulation (ANDA210588), expanding the competitive landscape in the diuretic and glaucoma treatment market. The approval is expected to increase price competition and improve patient access to this established therapeutic agent used for conditions including open-angle glaucoma, secondary glaucoma, and altitude sickness.